Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype.

Cell communication and signaling : CCS - 29 Jan 2026

Cadenas-Garrido Paula, García-Serna Azahara M, Parrado Antonio, Martínez-García Javier, Herrera-Suarez Marcela, Cánovas Manuel, de Diego Puente Teresa, Saceda Miguel, Pelegrin Pablo, Díaz-Carrasco María Sacramento, Martín-Orozco Elena

Abstract excerpt

BACKGROUND: Tumor cells have the capacity to develop coordinated resistance mechanisms that promote their survival and progression through the acquisition of multidrug resistance (MDR). This phenotype is the consequence of global cellular changes caused by antineoplastic drugs and may include modifications in the secretome, which influence the antitumoral immune response and the fate of resistant cells. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Cytokines

Share to Drug Resistance, Neoplasm

Share to Leukemia

Share to p38 Mitogen-Activated Protein Kinases

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 41612452
DOI: 10.1186/s12964-026-02653-1
PMCID: PMC12964735

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype.PMID 41612452Read ↗

Managing Cancer Drug Resistance from the Perspective of InflammationSemantic proximity Read ↗

Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells.Semantic proximity Read ↗

A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells.Semantic proximity Read ↗

Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.Semantic proximity Read ↗

Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular TargetingSemantic proximity Read ↗

Acquisition of MDR phenotype by leukemic cells is associated with increased caspase-3 activity and a collateral sensitivity to cold stress.Semantic proximity Read ↗

Role of the p38 MAPK pathway in cisplatin-based therapy.Semantic proximity Read ↗

Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.Semantic proximity Read ↗

Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosisSemantic proximity Read ↗

Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance.Semantic proximity Read ↗

Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.Semantic proximity Read ↗

Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.